Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)

China flag China · Delayed Price · Currency is CNY
4.920
-0.050 (-1.01%)
Jun 18, 2026, 3:04 PM CST
Market Cap5.20B +37.0%
Revenue (ttm)759.50M -6.6%
Net Income-135.94M
EPS-0.13
Shares Out 1.06B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,643,940
Open5.040
Previous Close4.970
Day's Range4.810 - 5.080
52-Week Range3.500 - 6.860
Beta0.33
AnalystsStrong Buy
Price Target13.85 (+181.5%)
Earnings DateAug 24, 2026

About SHE:300006

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. The company was founded in 1999 and is headquartered in Chongqing, China. [Read more]

Sector Healthcare
Founded 1999
Employees 973
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300006
Full Company Profile

Financial Performance

In 2025, SHE:300006's revenue was 775.69 million, a decrease of -2.50% compared to the previous year's 795.60 million. Losses were -134.71 million, 53.4% more than in 2024.

Financial Statements